Search results
PROMOTED
How do worsening heart events dictate the long-term outcomes of patients with transthyretin amyloid cardiomyopathy (ATTR-CM) and can earlier intervention influence the disease trajectory in ATTR-CM? In this new sub-analysis from ATTRibute-CM, recorded onsite at ESC Heart Failure Congress (HFA) 2026, Prof Marianna Fontana (University College London, London, UK) sheds further light onto these…
View more
HFA 2026: Updates on ATTR-CM
Author(s):
Marianna Fontana
,
Added:
3 weeks ago
Video Series
Author(s):
Daryl Dakay
,
Marion Patricio
Added:
1 month ago
SGLT2 Inhibitors in Acute Heart Failure
Author(s):
Hugo Prado-Prado
,
Sergio Raposeiras-Roubín
Added:
3 months ago
Viewpoint
Oral P2Y12 Inhibitors and Drug Interactions
Author(s):
Elisabetta Bigagli
,
Jacopo Angelini
,
Alessandro Mugelli
,
et al
Added:
12 months ago
Review Article
Factor XIa Inhibitors’ Future Position in AF
Author(s):
Maki Komiyama
,
Moritake Iguchi
,
Hiromichi Wada
,
et al
Added:
1 year ago
Expert Opinion
David Wheeler
Research Area(s) / Expertise:
Job title: Professor of Kidney Medicine
Author
Author(s):
Laura Pérez Bacigalupe
,
Laura López Ruiz
,
Beatriz Nieves Ureña
,
et al
Added:
1 month ago
Author(s):
Laura Pérez Bacigalupe
,
Laura López Ruiz
,
Beatriz Nieves Ureña
,
et al
Added:
1 month ago
Salvatore Carbone
Job title: PhD, RD, FHFSA, FASPEN
Author
Author(s):
Alberto Alen Andrés
,
María Salgado
,
Maria Fernández García
,
et al
Added:
1 month ago